MEI Pharma, BeiGene to co-develop cancer drug

MEI Pharma, a late-stage pharmaceutical company focused on advancing new therapies for cancer and BeiGene, a commer...

October 12, 2018 | Friday | News
Rgenix raises $40 M in series C funding

Rgenix, Inc., a clinical stage biopharmaceutical company developing first-in-class small molecule and antibody cancer th...

October 12, 2018 | Friday | News
UniCAR teams up with Terumo BCT to improve CAR T-cell therapies

Shanghai UniCAR-Therapy Bio-Medicine Technology Co. chose Terumo BCT and its cell expansion devices to automate its cell...

October 11, 2018 | Thursday | News
Jinxin Fertility announces completion of major financing round

With a potential market size of more than RMB100 billion, assisted reproduction has become one of the fastest growing ma...

October 10, 2018 | Wednesday | News
PolyU team develops new system for elderly care

The Hong Kong Polytechnic University (PolyU) has developed eNightLog, a multi-function nighttime monitoring system for e...

October 10, 2018 | Wednesday | News
Yisheng receives approval for rabies vaccine clinical study

Yisheng Biopharma Co., Ltd., a biopharmaceutical company focusing on research, development, manufacturing, sales and mar...

October 10, 2018 | Wednesday | News
AI based healthcare startup raises $15M funding

Deep Intelligent Pharma, a healthcare AI start-up providing new drug research and development services for pharmaceutica...

October 9, 2018 | Tuesday | News
CASI Pharmaceuticals appoints new president for China Operations

CASI Pharmaceuticals, a biopharmaceutical company dedicated to the development and delivery of high quality, cost-effect...

October 8, 2018 | Monday | News
Cellular Bio gets NCI patent license for solid tumour immunotherapy

Cellular Biomedicine Group Inc. (CBMG), a clinical-stage biopharmaceutical firm engaged in the development of immunother...

October 5, 2018 | Friday | News
AXA Hong Kong, HKSH medical group enter into collaboration

AXA Hong Kong and HKSH Medical Group has entered into collaboration under which HKSH will be the first and biggest partn...

October 4, 2018 | Thursday | News
Hong Kong Department of Health approves Biktarvy

Singapore - Gilead Sciences announced that the Hong Kong Department of Health has approved Biktarvy (bictegravir 50mg/em...

October 3, 2018 | Wednesday | News
PAGD enters into an agreement with Grab

China's leading one-stop healthcare ecosystem platform, Ping An Good Doctor (PAGD) has announced that it has entered int...

October 3, 2018 | Wednesday | News
CANbridge Pharma submits NDA for NERLYNX in China

CANbridge Pharmaceutical Inc., a biopharmaceutical company developing Western drug candidates in China and North Asia, a...

October 2, 2018 | Tuesday | News
CSPC Pharma, Verastem sign license agreement for cancer treatment

Verastem, Inc., focused on developing and commercializing medicines to improve the survival and quality of life of cance...

October 1, 2018 | Monday | News
Novartis collaborates with Cellular Biomedicine for CAR-T Therapy

Cellular Biomedicine Group Inc. (CBMG) has entered into a strategic licensing and collaboration agreement with Novartis ...

September 28, 2018 | Friday | News
DiaMedica, Ahon Pharma sign license agreement for stroke treatment

Ahon Pharmaceutical Co Ltd., a subsidiary of Shanghai Fosun Pharmaceutical (Group) Co. Ltd, and DiaMedica Therapeutics I...

September 28, 2018 | Friday | News
Ganovo gets enrolled in basic medical Insurance of Tianjin

Ascletis Pharma Inc. announced that Ganovo (Danoprevir) has been enrolled in the Basic Medical Insurance of Tianjin...

September 27, 2018 | Thursday | News
WuXi, I-Mab collaborate to develop three bispecific antibodies

WuXi Biologics, a leading global open-access biologics technology platform company offering end-to-end solutions for bio...

September 27, 2018 | Thursday | News